Patents by Inventor John Wikstrand

John Wikstrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulation comprising a betablocker and optionally a cholestrol-lowering agent
    Publication number: 20060252814
    Abstract: The present invention relates to pharmaceutical formulations comprising a betablocker, in a maintenance dose lower than 50 mg, particularly in the range of 25 to 47 mg, optionally containing a cholesterol lowering agent, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a method of treatment and use of the formulations for the treatment of atherosclerosis and related diseases.
    Type: Application
    Filed: April 19, 2006
    Publication date: November 9, 2006
    Applicant: AstraZeneca AB
    Inventors: Goran Berglund, John Wikstrand
  • Combination of a betablocker and a cholesterol-lowering agent
    Publication number: 20040192784
    Abstract: The present invention relates to pharmaceutical formulations comprising a betablocker and a cholesterol-lowering agent in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treatment and use of the formulations for the prophylactic or therapeutic treatment of atherosclerosis, hypercholesterolemia and hyperlipoproteinemia.
    Type: Application
    Filed: April 14, 2004
    Publication date: September 30, 2004
    Applicant: AstraZeneca AB
    Inventors: Goran Bondjers, Olov Wiklund, John Wikstrand
  • Fomulation
    Publication number: 20030191177
    Abstract: The present invention relates to pharmaceutical formulations comprising a betablocker, in a maintenance dose lower than 50 mg, particularly in the range of 25 to 47 mg, optionally containing a cholesterol lowering agent, in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a method of treatment and use of the formulations for the treatment of atherosclerosis and related diseases.
    Type: Application
    Filed: December 13, 2002
    Publication date: October 9, 2003
    Inventors: Goran Berglund, John Wikstrand
  • Combination of a betablocker and a cholesterol-lowering agent
    Publication number: 20030060477
    Abstract: The present invention relates to pharmaceutical formulations comprising a betablocker and a cholesterol-lowering agent in admixture with a pharmaceutically acceptable adjuvant, diluent or carrier, as well as a kit of parts, a method for treatment and use of the formulations for the prophylactic or therapeutic treatment of atherosclerosis, hypercholesterolemia and hyperlipoproteinemia.
    Type: Application
    Filed: September 4, 2002
    Publication date: March 27, 2003
    Inventors: Goran Bondjers, Olov Wiklund, John Wikstrand